Search results
Results from the WOW.Com Content Network
Aflibercept, sold under the brand names Eylea and Zaltrap among others, is a medication used to treat wet macular degeneration and metastatic colorectal cancer. [ 14 ] [ 15 ] It was developed by Regeneron Pharmaceuticals .
Two of the most highly successful compounds to win FDA approval in the past few years have been Regeneron's Eylea and Novartis' and Roche's Lucentis. Both drugs help improve vision in patients who ...
The agency approved Biocon Biologics' Yesafili as well as Samsung Bioepis and Biogen's Opuviz, while also allowing interchangeability, or the drug's substitution with biosimilars without the need ...
For premium support please call: 800-290-4726 more ways to reach us
Medication costs can be the selling price from the manufacturer, that price together with shipping, the wholesale price, the retail price, and the dispensed price. [3]The dispensed price or prescription cost is defined as a cost which the patient has to pay to get medicines or treatments which are written as directions on prescription by a prescribers. [4]
From or to a drug trade name: This is a redirect from (or to) the trade name of a drug to (or from) the international nonproprietary name (INN).
Lawmakers and PBM critics say higher drug prices lead to higher fees to PBMs; the higher the price of a covered drug, the steeper the potential discount, some of which PBMs keep as profit.
Cost–utility analysis (CUA) is a form of economic analysis used to guide procurement decisions. The most common and well-known application of this analysis is in pharmacoeconomics , especially health technology assessment (HTA).